- Angelika Tillmann
- Vice President Global Clinical Quality Assurance & Compliance
- Covance, Germany
An industry expert with more than 10 years of experience in academic research at the University of Essen, and more than 25 years of industry experience primarily in quality assurance and compliance in pharma and clinical research, Angelika Tillmann is currently employed as Vice President of Clinical Quality Assurance & Compliance at Covance.
Angelika establishes best practice standards for the global Clinical QA and Compliance Team, managing and overseeing all Clinical QA & Compliance related activities around the globe, including oversight of the conduct of the entire range of audits for all phases of clinical trials, and internal process/ systems audits.
As Head of Covance’s Clinical Compliance Framework Angelika is responsible for oversight on advice on compliance to relevant regulatory requirements, impact analysis of new regulatory requirements on Covance processes and development and implementation of robust and compliant processes and underlying procedural documents, development and implementation of Covance’s risk management framework including operational quality metrics, development and implementation of corrective and preventive action plans (CAPAs), and the implementation of quality improvement initiatives.
Angelika is a member of the EMA Expert Stakeholder Group advising on the implementation of the European Clinical Trial Regulation Portal and Database since 2014.
Angelika is a Fellow of the Research Quality Association (RQA) and the Secretary of RQA’s GCP Committee. Angelika is also a member of the German Quality Management Association (GQMA) (formerly DGGF) in Germany since 1998 and a member of the GQMA’s Working Group on Risk Management since its inception in 2013.
Angelika is the author of numerous industry publications and frequently presents at international conferences.